Queen Mary University of London
5 days ago
PhD in Specialised Pro-Resolving Mediators, Haematopoiesis, Rheumatoid Arthritis and Cardiovascular Disease Queen Mary University of London in United Kingdom
Degree Level
PhD
Field of study
Inflammation
Funding
Fully funded Doctoral Candidate position within HARPNET, a Marie Skłodowska-Curie Actions Doctoral Network. Funding includes an employment contract plus applicable MSCA living and mobility allowances; family allowances may apply where eligible.
Deadline
Oct 1, 2026
Country
United Kingdom
University
Queen Mary University of London
How do I apply for this?
Sign in for free to reveal details, requirements, and source links.
Apply for this position
Keywords
Suggested positions
About this position
PhD opportunity at Queen Mary University of London (William Harvey Research Institute) in specialised pro-resolving mediators (SPMs), haematopoiesis, rheumatoid arthritis, and cardiovascular disease.
This project investigates how chronic inflammatory disease alters bone-marrow output and whether SPMs can restore balanced haematopoietic stem and progenitor-cell activity, reduce inflammatory myeloid-cell production, and identify biomarkers of altered haematopoiesis. The research sits at the interface of immunology, haematology, molecular biology, cell biology, and pharmacology, with strong translational relevance to inflammatory disease and cardiovascular injury.
Training includes isolation and phenotyping of haematopoietic stem/progenitor cells, multiparameter flow cytometry, colony-forming assays, bone-marrow and myeloid-differentiation models, experimental arthritis and cardiovascular disease models, SPM pharmacology, transcriptomic profiling, and biomarker development.
Applicants should have, or expect to obtain by October 2026, a Master’s degree (or equivalent) that allows doctoral enrolment at QMUL. A background in immunology, haematology, cell biology, pharmacology, or molecular medicine is desirable, and experience with flow cytometry, primary-cell culture, or molecular biology is an advantage. Candidates must be proficient in English and meet the MSCA mobility rule.
This is a fully funded Doctoral Candidate position in the HARPNET Marie Skłodowska-Curie Actions Doctoral Network, with an employment contract and applicable living and mobility allowances; family allowances may apply where eligible.
Apply via the central HARPNET recruitment portal and rank up to three project choices. Deadline shown on the listing: 2026-10-01. For queries, contact [email protected].
Funding details
Fully funded Doctoral Candidate position within HARPNET, a Marie Skłodowska-Curie Actions Doctoral Network. Funding includes an employment contract plus applicable MSCA living and mobility allowances; family allowances may apply where eligible.
What's required
Applicants should have, or expect to obtain by October 2026, a Master’s degree or equivalent that permits doctoral enrolment at Queen Mary University of London. A background in immunology, haematology, cell biology, pharmacology or molecular medicine is preferred. Experience with flow cytometry, primary-cell culture or molecular biology is desirable. Candidates must be proficient in English and satisfy the MSCA mobility rule: they must not have resided or carried out their principal activity in the United Kingdom for more than 12 months in the 36 months immediately preceding recruitment. Applicants must not already hold a doctoral degree.
How to apply
Visit the HARPNET recruitment page for full details and submit one central HARPNET application. You may rank up to three project choices. For application queries, contact [email protected].
More information can be found here
Ask ApplyKite AI
How do I apply for this?
Sign in for free to reveal details, requirements, and source links.